Fachapotheker In FPH Spital Practice Questions - Fachapotheker In FPH In Spitalpharmazie Pharmacien Ne Spécialiste FPH En Pharmacie Hospitalière Exam

Access More Questions

Under the Swiss Human Research Act (HFG) and Clinical Trials Ordinance (KlinV), what regulatory authorization is required before a hospital pharmacy can manufacture and release an unapproved Investigational Medicinal Product (IMP) for a Category C clinical trial?

Approval from the cantonal ethics committee (Swissethics) and a formal clinical trial authorization from Swissmedic, with batch release by a Qualified Person (FPH Spital) Notification to the Swiss Federal Office of Public Health (BAG) without requiring formal ethics committee approval A valid cantonal retail pharmacy license (Offizinbewilligung) and written consent from the hospital medical director only An Investigational New Drug (IND) approval granted exclusively by the United States Food and Drug Administration (FDA)

Correct Answer:

Approval from the cantonal ethics committee (Swissethics) and a formal clinical trial authorization from Swissmedic, with batch release by a Qualified Person (FPH Spital)

Access more questions from this quiz

Continue to Fachapotheker in FPH Spital Practice Questions - Fachapotheker in FPH in Spitalpharmazie Pharmacien ne spécialiste FPH en pharmacie hospitalière Exam for more practice questions and the full quiz experience.

Access More Questions